A 74-year-old man presents to the emergency department with out-of-hospital cardiac arrest. Paramedics administered epinephrine prior to arrival to the hospital. The patient is unresponsive but has a faint pulse. You wonder about the long-term benefits of epinephrine, which is still recommended by the American Heart Association. 
THREE-PART QUESTION

COMMENTS
Epinephrine is a fundamental part of advanced cardiac life support. It is said to increase coronary and cerebral perfusion. This alpha-adrenergic-mediated process is thought to contribute to ROSC in arrested patients. However, despite epinephrine's integral part in standard resuscitation protocols, there remains little evidence that epinephrine directly impacts patient survival or favourable neurological outcome. There is growing concern that epinephrine may actually be harmful to long-term outcomes by increasing myocardial dysfunction and altering cerebral microcirculation.
Clinical bottom line
Epinephrine used as an adjunctive treatment during OHCA improves ROSC and survival to hospital but not survival to discharge or neurological outcome. 
